佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: tk123

【SUNZEN 0148 交流专区】宏诚生科

[复制链接]
发表于 23-4-2014 04:07 AM | 显示全部楼层
EX-date
06/05/2014
Entitlement date
08/05/2014
Entitlement time
05:00:00 PM
Entitlement subject
Interim Dividend
Entitlement description
A single-tier interim dividend of RM0.008 per ordinary share of RM0.10 each in respect of the financial year ending 31 December 2014
Period of interest payment
to
Financial Year End

Share transfer book & register of members will be
to closed from (both dates inclusive) for the purpose of determining the entitlements
Registrar's name ,address, telephone no
Symphony Share Registrars Sdn Bhd
Level 6 Symphony House
Block D13, Pusat Dagangan Dana 1
Jalan PJU 1A/46
47301 Petaling Jaya
Selangor Darul Ehsan
Tel: 603.7841.8000
Payment date
22/05/2014
a.Securities transferred into the Depositor's Securities Account before 4:00 pm in respect of transfers
08/05/2014
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit

c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)

Entitlement indicator
Currency
Currency
Malaysian Ringgit (MYR)
Entitlement in Currency
0.008

回复

使用道具 举报


ADVERTISEMENT

发表于 1-6-2014 04:41 PM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2014
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/03/2014
31/03/2013
31/03/2014
31/03/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
8,435
8,174
8,435
8,174
2Profit/(loss) before tax
381
797
381
797
3Profit/(loss) for the period
261
668
261
668
4Profit/(loss) attributable to ordinary equity holders of the parent
261
668
261
668
5Basic earnings/(loss) per share (Subunit)
0.17
0.45
0.17
0.45
6Proposed/Declared dividend per share (Subunit)
0.80
0.00
0.80
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.2200
0.2200

回复

使用道具 举报

发表于 11-7-2014 04:31 AM | 显示全部楼层
Notice of Person Ceasing (29C)
SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder
Name
Fong Chan Seng
Address
12 Jalan USJ 5/4C
47610 Subang Jaya
Selangor Darul Ehsan
NRIC/Passport No/Company No.
470905-02-5365
Nationality/Country of incorporation
Malaysian
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Date of cessation
09/07/2014
Name & address of registered holder
Fong Chan Seng
12 Jalan USJ 5/4C
47610 Subang Jaya
Selangor Darul Ehsan
Currency
Malaysian Ringgit (MYR)
Number of securities disposed
10,436,000
Price Transacted ($$)

Circumstances by reason of which a person ceases to be a substantial securities Holder
Disposal of Shares
Nature of interest
Direct
Date of notice
10/07/2014

回复

使用道具 举报

发表于 12-7-2014 04:18 AM | 显示全部楼层
Notice of Person Ceasing (29C)
SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder
Name
Teo Kim Lai
Address
168-9-5 Kiara Park Condominium
Jalan Burhanuddin Helmi
Taman Tun Dr Ismail
60000 Kuala Lumpur
Wilayah Persekutuan
NRIC/Passport No/Company No.
630103-01-5413
Nationality/Country of incorporation
Malaysian
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Date of cessation
10/07/2014
Name & address of registered holder
Teo Kim Lai
168-9-5 Kiara Park Condominium
Jalan Burhanuddin Helmi
Taman Tun Dr Ismail
60000 Kuala Lumpur
Wilayah Persekutuan
Currency
Malaysian Ringgit (MYR)
Number of securities disposed
4,200,000
Price Transacted ($$)

Circumstances by reason of which a person ceases to be a substantial securities Holder
Disposal of shares via married deal
Nature of interest
Direct
Date of notice
11/07/2014

回复

使用道具 举报

发表于 15-7-2014 03:18 AM | 显示全部楼层
Date of change
14/07/2014
Name
Hong Choon Hau
Age
37
Nationality
Malaysian
Type of change
Redesignation
Previous Position
Non-Executive Director
New Position
Non-Executive Director
Directorate
Non Independent & Non Executive
Qualifications
Diploma in Computer Science/Information Technology
Working experience and occupation
2011 -2012
- Executive Director of MBI Mobile Marketing

2012 - 2013
- Executive Director of Gameview Sdn Bhd

2013 - Current
- Director of Play4fun Sdn Bhd

2014 - Current
- Group Executive Director/Financial Controller of Myworld Holdings Berhad
Directorship of public companies (if any)
Myworld Holdings Berhad
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Mr Hong holds 41,046,000 ordinary shares and 12,000,000 warrants in the Company

回复

使用道具 举报

发表于 16-7-2014 09:01 PM | 显示全部楼层
宏诚生科27.5%场外易手

财经新闻 财经  2014-07-16 08:14
(吉隆坡15日讯)宏诚生科(SUNZEN,0148,创业板)共有4105万股,或27.5%股权在场外易手,每股作价26仙,总值1067万令吉。

相比昨日的闭市价37仙,也是历史闭市新高,这批场外交易的股票折价29.73%。

该股是在32.5仙至38.5仙区间交易,成交量有987万3800股。

宏诚生科WA也有场外交易,在公开市场也交投活络。

共有1660万凭单在场外易手,每张16仙,总值约266万令吉。

宏诚生科WA昨日则收于29仙,扬5.5仙,或23.4%,成交量有480万4700张。

最近,公司一些董事在脱售持股权。单是7月,执行董事方晨成(译音)售出1044万股,持股权从11.01%,降至4.02%。

另一名执行董事郭培楚(译音)也将持股权,从12.7%,减至上周五的8.84%。

宏诚生科截至12月的2013财年净利大涨149%,报351万令吉,上财年为142万令吉。营业额则扬13.81%,达3733万令吉。【南洋网财经】
回复

使用道具 举报

Follow Us
发表于 17-7-2014 02:17 AM | 显示全部楼层
Notice of Person Ceasing (29C)
SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder
Name
Tan Kim Sing
Address
16 Jalan SS 18/1A
47500 Subang Jaya
Selangor Darul Ehsan
NRIC/Passport No/Company No.
490805-02-5075
Nationality/Country of incorporation
Malaysian
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Date of cessation
14/07/2014
Name & address of registered holder
Tan Kim Sing
16 Jalan SS 18/1A
47500 Subang Jaya
Selangor Darul Ehsan
Currency
Malaysian Ringgit (MYR)
Number of securities disposed
41,046,000
Price Transacted ($$)

Circumstances by reason of which a person ceases to be a substantial securities Holder
Disposal of shares
Nature of interest
Direct
Date of notice
16/07/2014



Notice of Interest Sub. S-hldr (29A)
Particulars of Substantial Securities Holder
Name
Hong Choon Hau
Address
10, Jalan Margosa SD10/4C
Bandar Sri Damansara
52200 Kuala Lumpur
NRIC/Passport No/Company No.
761113-02-5869
Nationality/Country of incorporation
Malaysian
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Name & address of registered holder
Hong Choon Hau
10, Jalan Margosa SD10/4C
Bandar Sri Damansara
52200 Kuala Lumpur
Date interest acquired & no of securities acquired
Currency
Malaysian Ringgit (MYR)
Date interest acquired
14/07/2014
No of securities
41,046,000
Circumstances by reason of which Securities Holder has interest
Acquisition of shares
Nature of interest
Direct
Price Transacted ($$)

Total no of securities after change
Direct (units)
41,046,000
Direct (%)
27.5
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Date of notice
16/07/2014
回复

使用道具 举报

发表于 18-7-2014 04:11 AM | 显示全部楼层
Name
Teo Kim Lai
Address
168-9-5 Kiara Park Condominium
Jalan Burhanuddin Helmi
Taman Tun Dr Ismail
60000 Kuala Lumpur
Wilayah Persekutuan
Descriptions(Class & nominal value)
Ordinary Shares of RM0.10 each
Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction
Date of change
No of securities
Price Transacted (RM)
Disposed
16/07/2014
4,259,000
0.260

Circumstances by reason of which change has occurred
Disposal of shares via married deal
Nature of interest
Direct
Consideration (if any)

Total no of securities after change
Direct (units)
1,179,060
Direct (%)
0.79
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Date of notice
17/07/2014





Name
Fong Chan Seng
Address
12, Jalan USJ 5/4C
47610 Subang Jaya
Selangor Darul Ehsan
Descriptions(Class & nominal value)
Ordinary Shares of RM0.10 each
Details of changes

Currency: Malaysian Ringgit (MYR)

Type of transaction
Date of change
No of securities
Price Transacted (RM)
Disposed
16/07/2014
2,000,000
0.260

Circumstances by reason of which change has occurred
Disposal of shares
Nature of interest
Direct
Consideration (if any)

Total no of securities after change
Direct (units)
4,000,860
Direct (%)
2.68
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Date of notice
17/07/2014
回复

使用道具 举报


ADVERTISEMENT

发表于 18-7-2014 04:54 AM | 显示全部楼层
Date of change
17/07/2014
Name
Teo Kim Lai
Age
51
Nationality
Malaysian
Designation
Executive Director
Directorate
Executive
Type of change
Resignation
Reason
Personal reason
Details of any disagreement that he/she has with the Board of Directors
No
Whether there are any matters that need to be brought to the attention of the shareholders
No
Qualifications
Professional Degree of Doctor of Veterinary Medicine from Universiti Putra Malaysia
Working experience and occupation
Prior to joining Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”), Dr. Teo Kim Lai held the position of field veterinarian in Federal Flour Mill Berhad from 1989 to 1990, Operational Manager in Oriental Feedmill, which under the wings of Robert Kuok’s Group in Lioaning, China from 1991 to 1992, Poultry Team Leader in Pfizer from 1993 to 1994, General Manager in Mallinckrodt Inc of China and Hong Kong in 1995, and General Team Leader and National Sales Manager in Pfizer from 1996 to 1998. In 1998, Dr. Teo together with the existing management of Pfizer in Malaysia, established Sunzen Corporation to undertake a management buy-out of Pfizer’s local distribution and marketing operations. Dr. Teo was then appointed as a Director of Sunzen Corporation since its inception.

Dr. Teo was the Vice President of the Malaysia Association of Food Animal from 2000 to 2001 and the Vice President of the Veterinary Alumni of UPM from 2003 to 2004. Dr.Teo was also a volunteer veterinary officer of the National Virus Eradication Campaign of the Department of Veterinary Services of the Ministry of Agriculture in 1999 and later became an adviser on the Technical Advisory Committee of Federation of Farmers Association Malaysia in 2000. Dr. Teo is currently an Honorary Secretary of World Poultry Science Association Malaysia Branch since 2008. He was the Honorary Secretary of Malaysia Iran Business Council from 2009 to 2010.
Directorship of public companies (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Dr. Teo holds 1,179,060 ordinary shares and 192,686 warrants in the Company

回复

使用道具 举报

发表于 20-7-2014 10:51 PM | 显示全部楼层
icy97 发表于 17-7-2014 02:17 AM
Notice of Person Ceasing (29C)
Particulars of substantial Securities Holder

宏诚生科新董事 持27.5%最大股东

财经新闻 财经  2014-07-19 12:30
(吉隆坡18日讯)宏诚生科(SUNZEN,0148,创业板)最近委任的非独立非执行董事洪俊豪(译音),崛起成为最大单一股东,持股27.5%。

宏诚生科向大马交易所报备,洪俊豪在本周一购入4105万股,相等于27.5%股权。

同日,主席兼董事经理陈健生脱售同等数额的股票,不再是公司大股东。

此外,洪俊豪以每张16仙,认购1200万凭单,持有权为24.12%。

周一,共有4105万股,每股作价26仙,以及1660万凭单,每张16仙,在场外易手。【南洋网财经】

回复

使用道具 举报

发表于 21-7-2014 07:12 PM | 显示全部楼层
Date of change
18/07/2014
Name
Fong Chan Seng
Age
66
Nationality
Malaysian
Designation
Executive Director
Directorate
Executive
Type of change
Resignation
Reason
Personal reason
Details of any disagreement that he/she has with the Board of Directors
No
Whether there are any matters that need to be brought to the attention of the shareholders
No
Qualifications
Bachelor of Veterinary Science and Animal Husbandry degree from Bombay Veterinary College, India.
Working experience and occupation
Dr. Fong Chan Seng has thirty seven (37) years of industry experience. He held several job portfolios during his employment with Pfizer - Malaysia. Dr. Fong joined Pfizer as Veterinary Promotions Manager in 1981. Throughout seven (7) years of serving the domestic market in Malaysia, he held positions as Product Manager, National Sales Manager and Feedmill Marketing Manager. Dr. Fong was posted to Thailand as the Business Manager of Pfizer Thailand Ltd for three (3) years from 1988 to 1990. He was promoted to the position of Regional Director of Sales for Association of South East Asia Nation (“ASEAN”) countries in 1991.

In 1998, Dr. Fong together with the existing management of Pfizer in Malaysia, established Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”) to undertake a management buy-out of Pfizer’s local distribution and marketing operations. In 2001, Dr. Fong left Sunzen Corporation to join Phibro Animal Health Inc, USA as Regional Director for ASEAN countries and as Managing Director of their local incorporated company, Phibro Malaysia Sdn Bhd. He rejoined Sunzen Corporation in 2002.
Directorship of public companies (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Dr. Fong holds 4,000,860 shares and 953 warrants in the Company

回复

使用道具 举报

发表于 22-7-2014 04:40 AM | 显示全部楼层
宏诚生科主席呈辞 新大股东任CEO

财经新闻 财经  2014-07-23 11:34
(吉隆坡22日讯)宏诚生科(SUNZEN,0148,创业板)主席兼董事经理陈健生以私人原因为由,辞去职务。

早前崛起成为单一大股东的洪俊豪(译音),受委任成为总执行长,他之前是非独立非执行董事。

洪俊豪于公司持有4104万6000股,以及1200万凭单,同时也是Myworld控股执行董事兼财务总监。

同为独立非执行董事的林英才(译音),受委任为公司执行董事兼总营运长,任期由今日起生效。

林英才也是Ninetology(南区)有限公司总营运长,他于宏诚生科持有600万股,以及200万凭单。

宏诚生科非执行董事S古纳瑟哈然,也以私人原因为由辞职。【南洋网财经】

Date of change
21/07/2014
Name
Hong Choon Hau
Age
37
Nationality
Malaysian
Type of change
Redesignation
Previous Position
Non-Executive Director
New Position
Chief Executive Officer
Directorate
Executive
Qualifications
Diploma in Computer Science/Information Technology
Working experience and occupation
2011 -2012
- Executive Director of MBI Mobile Marketing

2012 - 2013
- Executive Director of Gameview Sdn Bhd

2013 - Current
- Director of Play4fun Sdn Bhd

2014 - Current
- Group Executive Director/Financial Controller of Myworld Holdings Berhad
Directorship of public companies (if any)
Myworld Holdings Berhad
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Mr Hong holds 41,046,000 ordinary shares and 12,000,000 warrants in the Company



Date of change
21/07/2014
Name
Tan Kim Sing
Age
64
Nationality
Malaysian
Designation
Chairman & Managing Director
Directorate
Executive
Type of change
Resignation
Reason
Personal reason
Details of any disagreement that he/she has with the Board of Directors
No
Whether there are any matters that need to be brought to the attention of the shareholders
No
Qualifications
- Bachelor of Veterinary Science and Animal Husbandry from Bombay Veterinary College in India (1975)
- Master of Philosophy in Veterinary Science from Massey University, New Zealand (1979)
Working experience and occupation
Dr. Tan Kim Sing has thirty five (35) years of experience in animal health industry, mainly involved in management, sales, marketing and technical services. Prior to forming Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”), he spent about twenty one (21) years with Pfizer. He started as Technical Manager in 1979 before becoming a Sales Manager, Product Manager, Premix Manager and Division Director. In 1998, Dr. Tan has together with the existing management of Pfizer in Malaysia, established Sunzen Corporation to undertake a management buy out of Pfizer’s local distribution and marketing operations. He was then appointed as the Managing Director of Sunzen Corporation since its inception.

Dr. Tan is currently the Vice President of the Malaysian Animal Health & Nutrition Industries Association and a member of the Malaysian Veterinary Council.
Directorship of public companies (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Dr. Tan holds 510 shares and 169 warrants in the Company



ate of change
21/07/2014
Name
Lim Eng Chai
Age
43
Nationality
Malaysian
Type of change
Redesignation
Previous Position
Non-Executive Director
New Position
Chief Operating Officer
Directorate
Executive
Qualifications
Diploma in Art & Design
Working experience and occupation
2014 - Current
- Chief Operating Officer of Ninetology (Southern) Sdn Bhd

2004 - Current
- Director of Excelcity Hi- Tech Sdn Bhd

2012 - Current
- Director of BP Excelcity Sdn Bhd(Celcom exclusive Partner -Kluang)

2012 - Current
- Director of Angsana Edar Sdn Bhd (TM Point Parit Raja)

2012 - Current
- Director of Angsana Venture Sdn Bhd (TM Point Batu Pahat Mall)
Directorship of public companies (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Mr. Lim holds 6,000,000 shares and 2,000,000 warrants in the Company
本帖最后由 icy97 于 24-7-2014 12:34 AM 编辑

回复

使用道具 举报

发表于 23-7-2014 02:40 AM | 显示全部楼层
Date of change
21/07/2014
Name
Tan Sri Haji Musa Bin Tan Sri Haji Hassan
Age
62
Nationality
Malaysian
Type of change
Appointment
Designation
Chairman
Directorate
Independent & Non Executive
Qualifications
- School Certificate and Malaysian Certificate of Education 1968
- Diploma In Law, University College of Wales Aberystwyth UK 1985
- Ijazah Kehormat Doktor Falsafah (Pengurusan Teknologi) 2010
- Advanced Management Program Templeton College University Oxford UK 2002
Working experience and occupation
- Investigation & Prosecution Officer in Malacca - 1970–1973
- Investigation Officer & Area Inspector Alor Gajah Malacca -1973-1975
- Intell and Ops Officer Drug Enforcement Branch Bkt Aman -1975-1986
- Law Lecturer and Head of Law School at Police College – 1986-1991
- Head of Police Law Examination Syndicate – 1991-1995
- Head of Legal Section CID – 1995-2000
- Deputy Director CID II – 2000-2001
- Deputy Director CID I – 2001-2003
- Chief Police Officer of Johore – 2003-2004
- Director of Criminal Investigation Dept. – 2004
- Deputy Inspector General of Police – 2005-2006
- Inspector General of Police – 2006-2010
Directorship of public companies (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Tan Sri Haji Musa Bin Tan Sri Haji Hassan holds 2,000,000 shares and 650,000 warrants in the Company.
本帖最后由 icy97 于 24-7-2014 01:08 PM 编辑

回复

使用道具 举报

发表于 23-7-2014 03:56 AM | 显示全部楼层
Notice of Person Ceasing (29C)
SUNZEN BIOTECH BERHAD

Particulars of substantial Securities Holder
Name
Kok Poe Chu
Address
25 Jalan USJ 3/4N
47600 UEP Subang Jaya
Selangor Darul Ehsan
NRIC/Passport No/Company No.
610412-02-5473
Nationality/Country of incorporation
Malaysian
Descriptions (Class & nominal value)
Ordinary Shares of RM0.10 each
Date of cessation
21/07/2014
Name & address of registered holder
Kok Poe Chu
25 Jalan USJ 3/4N
47600 UEP Subang Jaya
Selangor Darul Ehsan
Currency
Malaysian Ringgit (MYR)
Number of securities disposed
4,780,000
Price Transacted ($$)

Circumstances by reason of which a person ceases to be a substantial securities Holder
Disposal of shares
Nature of interest
Direct
Date of notice
22/07/2014

回复

使用道具 举报

发表于 27-7-2014 08:38 PM | 显示全部楼层
换了新董事,现在的价位能买吗
回复

使用道具 举报

发表于 31-8-2014 04:36 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2014
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2014
30/06/2013
30/06/2014
30/06/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
9,886
8,553
18,321
16,727
2Profit/(loss) before tax
317
770
698
1,567
3Profit/(loss) for the period
283
645
544
1,313
4Profit/(loss) attributable to ordinary equity holders of the parent
283
645
544
1,313
5Basic earnings/(loss) per share (Subunit)
0.19
0.43
0.36
0.88
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
0.2100
0.2200

回复

使用道具 举报


ADVERTISEMENT

发表于 9-10-2014 03:55 PM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
SUNZEN BIOTECH BERHAD (“SUNZEN” OR “COMPANY”)
– DISTRIBUTION AGREEMENT BETWEEN SUNZEN CORPORATION SDN BHD AND ZOETIS MALAYSIA SDN BHD
Reference is made to the Distribution Agreement made between Sunzen Corporation Sdn. Bhd. (“Sunzen Corporation”), a wholly-owned subsidiary of the Company and Zoetis Malaysia Sdn. Bhd. (“Zoetis”) dated 1 May 2011 as a result of the Novation Agreement dated 18 September 2012 and its extension (“Distribution Agreement”).

Pursuant to Rule 9.04(b) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of Sunzen wishes to announce that Zoetis had, on 3 October 2014, pursuant to the terms of the Distribution Agreement, served a notice to Sunzen Corporation, to confirm that the Distribution Agreement will expire on 31 December 2014 and both parties shall then immediately enter into good faith negotiations so as to establish the a contractual relationship.

As advised by Zoetis, the expiration of the Distribution Agreement and the mutual intention of re-establishing the new contractual relationship are made in order to align with the change of Zoetis Business Model. Zoetis will manage the companion animal portfolio while, upon the conclusion of the new contractual relationship, Sunzen Corporation is expected to enter into a 3-year non-exclusive distribution agreement for its products and then become Zoetis’ key swine portfolio partner.

There were no significant events leading to the service of the aforesaid notice of expiration of the Distribution Agreement by Zoetis. Zoetis had served the said notice of expiration pursuant to Clause 5 of the Distribution Agreement which provides that Zoetis may terminate the Distribution Agreement.

Zoetis is a major supplier of animal vaccines, veterinary pharmaceuticals and antibiotic feed additives for the Sunzen Group. Based on the audited consolidated financial statements of Sunzen for the financial year ended 31 December 2013, the Sunzen Group recorded a total revenue of RM37,325,958 of which Zoetis’ sales contributed RM6,595,452 or approximately 17% of its Group’s revenue.

There will be no operational impact to Sunzen Group as the manpower will be mobilised for other existing contracts for the supply of animal vaccines, veterinary pharmaceuticals and antibiotics feed additives to the customers.

The Board of Directors is of the view that the Sunzen Group’s future revenue and profitability may be affected due to the termination of the above Distribution Agreement and the Group’s revenue and probability may recover subsequently once the new distribution agreement is finalised.

This announcement is dated 8 October 2014.

回复

使用道具 举报

发表于 18-10-2014 10:12 PM | 显示全部楼层
Type
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
SUNZEN BIOTECH BERHAD (“SUNZEN” OR “COMPANY”)

PROPOSED PRIVATE PLACEMENT OF NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN, REPRESENTING NOT MORE THAN TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF SUNZEN (EXCLUDING TREASURY SHARES) (“PROPOSED PRIVATE PLACEMENT”)
On behalf of the Board of Directors of Sunzen, TA Securities Holdings Berhad wishes to announce that the Company proposes to undertake the Proposed Private Placement. Please refer to the attachment for further details of the announcement.

This announcement is dated 17 October 2014.

http://www.bursamalaysia.com/market/listed-companies/company-announcements/1768733
Attachments

回复

使用道具 举报

发表于 19-10-2014 12:23 PM | 显示全部楼层
私配1990万股 宏诚股冀筹696万
财经新闻 财经  2014-10-19 11:12
http://www.nanyang.com/node/656758

(吉隆坡18日讯)宏诚生科(SUNZEN,0148,创业板)建议发售最多1990万2000私下配售股,筹资最高696万6000令吉。

文告显示,将在稍后公布发售价,以及上述私配股的发售对象。

假设定价是每股35仙,则可最多筹得696万6000令吉。

公司计划把当中的675万6000令吉,用于提升和添购厂房和机械,余额则是该企业活动的成本。
本帖最后由 icy97 于 19-10-2014 01:34 PM 编辑

回复

使用道具 举报

发表于 22-10-2014 05:54 AM | 显示全部楼层
ype
Announcement
Subject
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING
Description
SUNZEN BIOTECH BERHAD (“SUNZEN” OR “COMPANY”)

PROPOSED PRIVATE PLACEMENT OF NEW ORDINARY SHARES OF RM0.10 EACH IN SUNZEN, REPRESENTING NOT MORE THAN TEN PERCENT (10%) OF THE ISSUED AND PAID-UP SHARE CAPITAL OF SUNZEN (EXCLUDING TREASURY SHARES) (“PROPOSED PRIVATE PLACEMENT”)
We refer to the announcement made on 17 October 2014 (“Announcement”) in relation to the Proposed Private Placement and wish to provide the following additional information. Unless otherwise defined, the definitions set out in the Announcement shall apply herein.

As stated in Note (1) in Section 2.6 of the Announcement, with the additional production lines, the Sunzen Group is expected to increase the current production capacity of its pilot plant of approximately 50kg of Orgacids-AQUA per hour to approximately 1,000kg of Orgacids-AQUA and Powder Fat per hour, which will facilitate the Group to produce and commercialise the abovementioned new complementary products.

The Sunzen Group is currently in discussion with several potential customers for the supply of Orgacids-AQUA and Powder Fat. However, no contract and order has been secured as at 17 October 2014 and the Sunzen Group expects to finalise the discussion in 2015. The Sunzen Group is also in the midst of promoting the said new complementary products via marketing activities. For instance, the Sunzen Group had together with its collaborators at Universiti Sains Malaysia disclosed the scientific findings of the said new complementary products at various local and international platforms which include Malaysia Agriculture, Horticulture and Agrotourism Show 2012 in Malaysia, Aquafeed Horizons Asia 2014 in Bangkok, Thailand and 16th International Symposium on Fish Nutrition and Feeding in Cairns, Australia.

This announcement is dated 21 October 2014.

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 28-3-2024 11:21 PM , Processed in 0.076019 second(s), 21 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表